COCH Envoy Medical, Inc.
$6.51▲ +0.15%
Healthcare
Other
Volume 40.4K
Avg Volume (10D) 19.6K
Key Metrics & Fundamentals
Market Cap
$50.38M
P/E Ratio
–
Div Yield
0.00%
52W Range
3.63 - 9.54
% vs 50 MA
471.20%
% vs 200 MA
714.06%
RSI-14
98.3
MACD Histogram
+0.7000
Beta (1Y vs SPY)
-4.90
Free Cash Flow
-$5.46M
Gross Rev
$51,000
Gross Profit
-$227,000
EBITDA
-$5.33M
COGS
$278,000
Operating Exp
$5.34M
Operating Income
-$5.57M
EBIT
-$5.57M
Pretax Income
-$5.98M
Net Income
-$5.98M
EPS (Diluted)
-0.07
Price & Volume History
Loading chart…
Recent News

Envoy Medical to Report Third Quarter 2026 Financial Results on Thursday, November 5th
TMX Newsfile · Oct 27, 2026 8:30 AM ET

IQVIA Holdings (IQV) Surpasses Q3 Earnings and Revenue Estimates
Zacks · Oct 27, 2026 7:15 AM ET

Envoy Medical Announces Reverse Stock Split
TMX Newsfile · Oct 22, 2026 8:30 AM ET

Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design
TMX Newsfile · Oct 20, 2026 8:30 AM ET

Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant
TMX Newsfile · Oct 12, 2026 8:30 AM ET

Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio
TMX Newsfile · Sep 22, 2026 8:30 AM ET

Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th
TMX Newsfile · Sep 2, 2026 8:30 AM ET

Are Medical Stocks Lagging Compugen (CGEN) This Year?
Zacks · Aug 21, 2026 9:40 AM ET
Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates
Zacks · Aug 10, 2026 9:45 AM ET
Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones
TMX Newsfile · Aug 10, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See COCH's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.